BRCA1 deficiency in mature CD8(+) T lymphocytes impairs antitumor immunity

Women with BRCA1 germline mutations have approximately an 80% lifetime chance of developing breast cancer. While the tumor suppressor function of BRCA1 in breast epithelium has been studied extensively, it is not clear whether BRCA1 deficiency in non-breast somatic cells also contribute to tumorigen...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Bogang, Qi, Leilei, Chiang, Huai-Chin, Pan, Haihui, Zhang, Xiaowen, Greenbaum, Alexandra, Stark, Elizabeth, Wang, Li-Ju, Chen, Yidong, Haddad, Bassem R., Clagett, Dionyssia, Isaacs, Claudine, Elledge, Richard, Horvath, Anelia, Hu, Yanfen, Li, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Basic Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896206/
https://www.ncbi.nlm.nih.gov/pubmed/36731891
http://dx.doi.org/10.1136/jitc-2022-005852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896206/
https://www.ncbi.nlm.nih.gov/pubmed/36731891
http://dx.doi.org/10.1136/jitc-2022-005852

Ejemplares similares